Organ-specific and tumor-size-dependent responses to sunitinib in clear cell renal cell carcinoma

BACKGROUND: Tyrosine kinase inhibitors (TKIs) have been used as standard therapy for patients with advanced renal cell carcinoma (RCC). However, information on factors predicting response to treatment with TKIs is lacking. This study aimed to assess the association between initial tumor size, involv...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tsuchiya, Norihiko, Yuasa, Takeshi, Maita, Shinya, Narita, Shintaro, Inoue, Takamitsu, Numakura, Kazuyuki, Saito, Mitsuru, Satoh, Shigeru, Yonese, Junji, Habuchi, Tomonori
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3975282/
https://ncbi.nlm.nih.gov/pubmed/24612599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2490-14-26
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky